World's Best Scientists 2026 revealed!
Nallasivam Palanisamy

Nallasivam Palanisamy

D-Index & Metrics

Molecular Biology

D-Index
70
Citations
22363
World Ranking
1406
National Ranking
715

Nallasivam Palanisamy publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Nallasivam Palanisamy sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 202 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Nallasivam Palanisamy D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Nallasivam Palanisamy sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 70 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Nallasivam Palanisamy is affiliated with the Henry Ford Health System in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Genetics, and Oncology.

Their scholarly output includes prominent work in prostate cancer treatment and research, prostate cancer diagnosis and treatment, ubiquitin and proteasome pathways, cancer genomics and diagnostics, RNA modifications and cancer, urologic and reproductive health conditions, and molecular biology techniques and applications.

Frequent publication venues for their work include Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Clinical Cancer Research, European Urology Open Science, and The Prostate.

Among their recent papers are:

  • "Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer," 2020, Nature Communications
  • "Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers," 2021, Clinical Cancer Research
  • "High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients," 2020, Cancers
  • "The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development," 2020, Clinical Cancer Research
  • "Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression," 2021, Nature Communications

Regular collaborators include Shannon Carskadon, Nilesh Gupta, Sean R. Williamson, Dhananjay Chitale, and Bushra Ateeq, with whom they have co-authored multiple publications.

Best Publications

  • The mutational landscape of lethal castration-resistant prostate cancer

    Catherine S. Grasso;Yi Mi Wu;Dan R. Robinson;Xuhong Cao

  • Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

    Sooryanarayana Varambally;Qi Cao;Ram Shankar Mani;Sunita Shankar

  • Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1 , an unannotated lincRNA implicated in disease progression

    John R Prensner;Matthew K Iyer;O Alejandro Balbin;Saravana M Dhanasekaran

  • Transcriptome Sequencing to Detect Gene Fusions in Cancer

    Christopher A. Maher;Chandan Kumar-Sinha;Xuhong Cao;Shanker Kalyana-Sundaram

  • The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

    Dimple Chakravarty;Andrea Sboner;Sujit S. Nair;Eugenia Giannopoulou

  • Whole-Genome Cartography of Estrogen Receptor α Binding Sites

    Chin-Yo Lin;Vinsensius B. B. Vega;Jane S. Thomsen;Tao Zhang

  • Rearrangements of the RAF Kinase Pathway in Prostate Cancer, Gastric Cancer and Melanoma

    Nallasivam Palanisamy;Bushra Ateeq;Shanker Kalyana-Sundaram;Dorothee Pflueger;Dorothee Pflueger

  • A Common Molecular Basis for Rearrangement Disorders on Chromosome 22q11

    Lisa Edelmann;Raj K. Pandita;Elizabeth Spiteri;Birgit Funke

  • Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

    J. Chad Brenner;Bushra Ateeq;Yong Li;Anastasia K. Yocum

  • Induced chromosomal proximity and gene fusions in prostate cancer

    Ram-Shankar Mani;Scott A. Tomlins;Kaitlin Callahan;Aparna Ghosh

  • Chimeric transcript discovery by paired-end transcriptome sequencing

    Christopher A. Maher;Nallasivam Palanisamy;John C. Brenner;Xuhong Cao

  • Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer

    Dan R. Robinson;Shanker Kalyana-Sundaram;Shanker Kalyana-Sundaram;Yi Mi Wu;Sunita Shankar

  • Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.

    Kerstin Heselmeyer-Haddad;Kathrin Sommerfeld;Nicole M. White;Nadia Chaudhri

  • Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs.

    Qizhou Lian;Qizhou Lian;Elias Lye;Elias Lye;Keng Suan Yeo;Eileen Khia Way Tan

  • Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers

    Shanker Kalyana-Sundaram;Chandan Kumar-Sinha;Sunita Shankar;Dan R. Robinson

  • Baculoviral Vector‐Mediated Transient and Stable Transgene Expression in Human Embryonic Stem Cells

    Jieming Zeng;Juan Du;Ying Zhao;Nallasivam Palanisamy

  • IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy

    Georgia Hatzivassiliou;Ira Miller;Jun Takizawa;Nallasivam Palanisamy

  • Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

    Bo Han;Rohit Mehra;Robert J Lonigro;Lei Wang

  • HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab

    Suthinee Ithimakin;Kathleen C. Day;Fayaz Malik;Qin Zen

  • Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer

    Qi Cao;Ram Shankar Mani;Bushra Ateeq;Saravana M. Dhanasekaran

Frequent Co-Authors

Arul M. Chinnaiyan
Arul M. Chinnaiyan University of Michigan–Ann Arbor
Javed Siddiqui
Javed Siddiqui University of Michigan–Ann Arbor
Sooryanarayana Varambally
Sooryanarayana Varambally University of Alabama at Birmingham
Scott A. Tomlins
Scott A. Tomlins University of Michigan–Ann Arbor
Xuhong Cao
Xuhong Cao University of Michigan–Ann Arbor
Rohit Mehra
Rohit Mehra University of Michigan–Ann Arbor
Christopher G. Maher
Christopher G. Maher University of Sydney
Saravana M. Dhanasekaran
Saravana M. Dhanasekaran University of Michigan–Ann Arbor
Dan R. Robinson
Dan R. Robinson University of Michigan–Ann Arbor
R. S. K. Chaganti
R. S. K. Chaganti Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology can also open doors to a wide range of online degrees and alternative career paths that intersect with life sciences and human health. For students looking to work directly with individuals and communities, social work online master's programs offer in-depth training for helping vulnerable populations. If you’re interested in mental processes and behavior, accelerated psychology masters programs can help you quickly gain expertise and start a new career.

Other online opportunities include online masters mental health counseling degrees, which prepare graduates for important roles in therapy and counseling. For those with an interest in law and investigation, completing a forensic psychology degree can be rewarding; learn more about how much does a forensic psychologist make and what this in-demand career entails.

These related online degrees offer flexible learning and can broaden your career options beyond the lab, connecting your molecular biology background with high-impact fields in healthcare, mental health, and social services.

Best Scientists Citing Nallasivam Palanisamy

Trending Scientists

Recently Published Articles